Count of new indications per drug | 3-year new indication exclusivities | 7-year new rare disease indication exclusivities | Total |
---|---|---|---|
Drugs with 1 new indication | 29 (83%) | 6 (17%) | 35 (100%) |
Drugs with 2 new indications | 32 (84%) | 6 (16%) | 38 (100%) |
Drugs with 3 or more new indications | 37 (86%) | 6 (33%) | 43 (100%) |
Total | 98 (84%) | 18 (16%) | 116 (100%) |